NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News Archive

You are here: Home > News > News for COVID-19

COVID-19 News

Drug could more effectively treat patients hospitalised with COVID-19 pneumonia, research finds

17 December 2021 · Listed under COVID-19, Musculoskeletal

Image link to post

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia. The CATALYST Trial tested the rheumatoid arthritis treatment namilumab as a potential therapeutic to treat patients who are hospitalised with COVID-19 ... READ MORE

People with long COVID after hospitalisation face limited recovery after one year

16 December 2021 · Listed under COVID-19, Imaging, Respiratory Medicine

Image link to post

People who were hospitalised with COVID-19 and continued to experience symptoms five months later show limited further recovery one year after hospital discharge, according to the latest results of a major national study looking at the long-term health impacts of COVID-19 on hospitalised ... READ MORE

COVID-19 infection more likely than vaccines to cause rare cardiovascular complications

14 December 2021 · Listed under COVID-19, Life-saving Vaccines, Translational Data Science

Image link to post

Researchers have reported the results of the largest ever study to compare the risks of cardiovascular events - such as myocarditis, pericarditis, and cardiac arrhythmia - between different vaccines and COVID-19 infection, and the first to investigate the association between cardiac events and the ... READ MORE

RECOVERY Trial launched in South Africa

9 December 2021 · Listed under COVID-19, Translational Data Science

The world’s largest clinical trial investigating treatments for COVID-19 has now been launched in South Africa, with the first patient recruited today. Since March 2020, the RECOVERY Trial, which is supported by the NIHR Oxford BRC, has discovered three effective treatments for COVID-19: the ... READ MORE

Study uncovers gene that doubles risk of death from COVID-19

5 November 2021 · Listed under COVID-19, Genomic Medicine

Image link to post

University of Oxford researchers have identified the gene responsible for doubling the risk of respiratory failure from COVID-19. Sixty percent of people with South Asian ancestry carry the high-risk genetic signal, which could partly explain the excess deaths seen in some UK communities, ... READ MORE

QCOVID study identifies vaccinated groups at highest risk hospitalisation and death

25 October 2021 · Listed under COVID-19, Digital Health from Hospital to Home

Image link to post

Researchers from the University of Oxford have identified which vaccinated people are at greatest risk from severe Covid-19 leading to hospitalisation or death, from 14 days after the second dose of vaccination, when substantial immunity should be expected. The research used the QCovid tool, ... READ MORE

RECOVERY Trial paper wins BMJ’s Research Paper of the Year Award

1 October 2021 · Listed under COVID-19, Translational Data Science

Image link to post

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has been announced as the 2021 winner of The British Medical Journal’s prestigious UK Research Paper of the Year Award.  The award recognises original UK research that has the potential to ... READ MORE

Moonshot initiative to develop affordable COVID-19 antivirals gets funding boost

27 September 2021 · Listed under COVID-19

Image link to post

The COVID Moonshot, a non-profit, open-science consortium of scientists from around the world dedicated to the discovery of globally affordable and easily-manufactured antiviral drugs against COVID-19 and future viral pandemics has received key funding of £8 million from the Wellcome Trust, on ... READ MORE

MAIT Cell activation may play role in COVID-19 deaths, study finds

17 September 2021 · Listed under COVID-19, Inflammation across Tissues

Image link to post

Oxford researchers have found a correlation between deaths from COVID-19 infections and a poorly coordinated systemic immune response, as well as increased activity by Mucosal Associated Invariant T cells, or ‘MAIT cells’. A study involving Oxford BRC-supported researchers published ... READ MORE

Study investigates responses to COVID-19 treatment in chronic lymphoid leukaemia patients

27 August 2021 · Listed under COVID-19, Gene and Cell Therapy, Oxford Blood Group

The COVID-19 pandemic has led to understandable anxiety within the blood cancer community about how their illness may affect their ability to overcome COVID-19 infection. Members of the Oxford Centre for Haematology have led a collaborative research project looking at the response of patients ... READ MORE

New study launched to understand vaccine escape

26 August 2021 · Listed under COVID-19, Inflammation across Tissues, Life-saving Vaccines, Modernising Medical Microbiology and Big Infection Diagnostics

Oxford researchers will be involved in a major new study seeking to understand why some people become infected after vaccination or prior infection while others do not Oxford BRC-supported investigators already involved in the Protective Immunity from T-Cells in Healthcare workers (PITCH) study ... READ MORE

Vaccination still best protection, but less effective against Delta variant, study finds

19 August 2021 · Listed under COVID-19, Modernising Medical Microbiology and Big Infection Diagnostics, Translational Data Science

The latest findings of an ongoing national study of COVID-19 immunity in households across the UK has found that the Pfizer-BioNTech and Oxford-AstraZeneca vaccines offer good protection against new infections of the Delta variant of concern, but that effectiveness is reduced compared with the Alpha ... READ MORE

Second study confirms benefits of budesonide in early stages of COVID-19

12 August 2021 · Listed under COVID-19, Respiratory Medicine

Image link to post

A UK-wide clinical study has confirmed the findings of an earlier Oxford BRC-supported study showing that the early treatment with the inhaled asthma medication budesonide speeds up recovery from COVID-19 and reduces the risk of hospitalisation and death. The latest study – part of the PRINCIPLE ... READ MORE

BRC-supported study receives Best Research Paper Award

9 August 2021 · Listed under Cardiovascular Medicine, COVID-19, Digital Health from Hospital to Home, Multimorbidity and Long-Term Conditions, Translational Data Science

Image link to post

A leading cardiology journal has named an academic paper written by Oxford BRC-supported researchers as its best research paper of 2020. The paper – which found that two common heart medication do not increase the risk of COVID-19 hospitalisation – was named by the BMJ Heart journal as the ... READ MORE

Liver problems common among COVID-19 patients, study finds

23 July 2021 · Listed under COVID-19, Inflammation across Tissues, Translational Data Science

A study by Oxford University researchers has found that liver problems are common among patients with COVID-19. Patient data revealed that baseline hypoalbuminemia (an possible indication that the liver is producing low levels of albumin) and rising alkaline phosphatase (ALP), which can be a ... READ MORE

Oxford studies benefit from government funding of long COVID research

19 July 2021 · Listed under COVID-19, Imaging

Image link to post

Thousands of people suffering with long COVID will benefit from new research programmes backed by £19.6 million to help better understand the condition, improve diagnosis and find new treatments. Among the 15 studies that will receive government funding through the National Institute for Health ... READ MORE

COVID-19 risk prediction tool wins national award

16 July 2021 · Listed under COVID-19, Translational Data Science

Image link to post

A COVID-19 risk prediction tool, developed with support from the NIHR Oxford Biomedical Research Centre (BRC) has won the Florence Nightingale Award for Excellence in Healthcare Data Analytics. The QCovid® COVID-19 Population Risk Assessment tool was developed by a cross-organisational team and ... READ MORE

Delayed second dose and third doses of the Oxford vaccine lead to heightened immune response to COVID-19

29 June 2021 · Listed under COVID-19, Life-saving Vaccines

Image link to post

A longer delay of up to 45 weeks between the first and second dose of the Oxford-AstraZeneca vaccine leads to enhanced immune response after the second dose, the latest research by the Oxford Vaccine Group has found. They also found that a third dose given more than six months after the second ... READ MORE

Latest data on immune response to COVID-19 reinforces need for vaccination

17 June 2021 · Listed under COVID-19, Inflammation across Tissues, Life-saving Vaccines, Modernising Medical Microbiology and Big Infection Diagnostics

Image link to post

A new study led by University of Oxford has found that previous infection, whether it was symptomatic or asymptomatic, does not necessarily protect you long term from COVID-19, particularly against new variants of concern. The PITCH Study (Protective Immunity from T cells to COVID-19 in Health ... READ MORE

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

17 June 2021 · Listed under COVID-19, Gene and Cell Therapy

Image link to post

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population. While this is expected to improve with the second dose, this important finding may help influence ... READ MORE

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Next Page »

Other News

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre